Have a personal or library account? Click to login
Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies Cover

Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies

Postępy Higieny i Medycyny Doświadczalnej
Volume 75 (2021): Issue 1 (January 2021)
By: Kamila Czora-Poczwardowska,  Radosław Kujawski,  Julia Słyńko-Krzyżostaniak,  Przemysław Ł. Mikołajczak and  Michał Szulc  
Open Access
|Dec 2021

Authors

Kamila Czora-Poczwardowska

kczora@ump.edu.pl

Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland

Radosław Kujawski

Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland

Julia Słyńko-Krzyżostaniak

Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland

Przemysław Ł. Mikołajczak

Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Plewiska, Poland

Michał Szulc

Department of Pharmacology, Poznan University of Medical Sciences, Poznań, Poland
DOI: https://doi.org/10.2478/ahem-2021-0007 | Journal eISSN: 1732-2693
Journal RSS Feed
Language: English
Page range: 959 - 969
Submitted on: Aug 16, 2020
|
Accepted on: Apr 16, 2021
|
Published on: Dec 29, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
orexins,
orexin receptors,
AUD,
reward system,
two-bottle choice model,
SB-334867
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Medicine,
Basic medical science,
Immunology

© 2021 Kamila Czora-Poczwardowska, Radosław Kujawski, Julia Słyńko-Krzyżostaniak, Przemysław Ł. Mikołajczak, Michał Szulc, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 75 (2021): Issue 1 (January 2021)Next article